Portal de Periódicos da CAPES

A Simple HPLC Method for Simultaneous Determination of Lopinavir, Ritonavir and Efavirenz

2003; Pharmaceutical Society of Japan; Volume: 51; Issue: 6 Linguagem: Inglês

10.1248/cpb.51.715

1347-5223

Yoshiko Usami, Tsuyoshi Oki, Masahiko Nakai, Masafumi Sagisaka, Tsuguhiro Kaneda,

Biochemical and Molecular Research

We developed a simple HPLC method for the simultaneous determination of lopinavir (LPV), ritonavir (RTV) and efavirenz (EFV) to evaluate the efficiency of co-administration of LPV/RTV and EFV in Japanese patients enrolled in a clinical study. The monitoring of LPV plasma concentration is important because co-administration of LPV/RTV with EFV sometimes decreases plasma concentrations of LPV caused by EFV activation of cytochrome P-450 3A. A solution of acetonitrile, methanol and tetramethylammonium perchlorate (TMAP) in dilute aqueous trifluoroacetic acid (TFA) has been used as the mobile phase in a HPLC method to elute LPV and RTV. We found that a solvent ratio of 45 : 5 : 50 (v/v/v) of acetonitrile/methanol/0.02 M TMAP in 0.2% TFA optimized separation of LPV, RTV and EFV. A column temperature of 30 °C was necessary for the reproducibility of the analyses. Standard curves were linear in the range 0.060 to 24.06 μg/ml for LPV, 0.010 to 4.16 μg/ml for RTV, and 0.047 to 37.44 μg/ml for EFV. Coefficients of variation (CVs) of LPV, RTV and EFV in intraday and interday assays ranged from 1.5 to 4.0%, 2.5 to 16.8% and 1.0 to 7.7%, respectively. Accuracies ranged from 100 to 110%, 101 to 116% and 99 to 106% for LPV, RTV and EFV, respectively. The extraction recoveries were 77—87, 77—83 and 81—91% for LPV, RTV and EFV, respectively.